Evidence map›Paper›PMID 35606795›Full record

ArticleGenome biology2022

Comprehensive assessment of differential ChIP-seq tools guides optimal algorithm selection.

Thomas Eder, Florian Grebien

Abstract read
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. ChIP-Rx: Arabidopsis Chromatin Profiling Using Quantitative ChIP-Seq.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  7. The Evolution of Next-Generation Sequencing Technologies.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Differential Analysis of Protein-DNA Binding Using ChIP-Seq Data.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Article
  15. CSSQ: a ChIP-seq signal quantifier pipeline.Frontiers in cell and developmental biology · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas EderInstitute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID 0000-0002-0932-2052
Florian GrebienInstitute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria. florian.grebien@vetmeduni.ac.at.ORCID 0000-0003-4289-2281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe analysis of chromatin binding patterns of proteins in different biological states is a main application of chromatin immunoprecipitation followed by sequencing (ChIP-seq). A large number of algorithms and computational tools for quantitative comparison of ChIP-seq datasets exist, but their performance is strongly dependent on the parameters of the biological system under investigation. Thus, a systematic assessment of available computational tools for differential ChIP-seq analysis is required to guide the optimal selection of analysis tools based on the present biological scenario.

resultsWe created standardized reference datasets by in silico simulation and sub-sampling of genuine ChIP-seq data to represent different biological scenarios and binding profiles. Using these data, we evaluated the performance of 33 computational tools and approaches for differential ChIP-seq analysis. Tool performance was strongly dependent on peak size and shape as well as on the scenario of biological regulation.

conclusionsOur analysis provides unbiased guidelines for the optimized choice of software tools in differential ChIP-seq analysis.

Indexed as

AlgorithmsChromatin Immunoprecipitation SequencingChromatin ImmunoprecipitationHigh-Throughput Nucleotide SequencingSequence Analysis, DNASoftwareBenchmarking differential ChIP-seq toolsBioinformatic analysisDifferential ChIP-seqGuidelines for differential ChIP-seq

Identifiers

PMID35606795
PMCPMC9128273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.